Reliance Chemotex Q3FY26 Results: Net Profit Surges 314% to ₹79.95 Lacs
Reliance Chemotex Industries announced strong Q3FY26 results with net profit surging 314% to ₹79.95 lacs despite revenue decline. The company demonstrated effective cost management with total expenses falling 12.31%, while nine-month profit grew 59.37% to ₹351.56 lacs, reflecting improved operational efficiency.

*this image is generated using AI for illustrative purposes only.
Reliance Chemotex Industries Ltd has announced its unaudited financial results for the third quarter and nine months ended December 31, 2025. The Board of Directors approved these results during their meeting held on February 11, 2026, through video conferencing from 11:39 AM to 12:10 PM.
Strong Q3FY26 Performance
The company demonstrated remarkable profitability improvement in Q3FY26, with net profit reaching ₹79.95 lacs compared to ₹19.31 lacs in the corresponding quarter of the previous year, marking a substantial 314% year-on-year growth. However, revenue from operations declined to ₹8,194.11 lacs from ₹9,222.98 lacs in Q3FY25, representing an 11.16% decrease.
| Financial Metric: | Q3FY26 | Q3FY25 | Change (%) |
|---|---|---|---|
| Revenue from Operations: | ₹8,194.11 lacs | ₹9,222.98 lacs | -11.16% |
| Total Income: | ₹8,234.34 lacs | ₹9,279.22 lacs | -11.26% |
| Total Expenses: | ₹8,126.18 lacs | ₹9,267.48 lacs | -12.31% |
| Profit Before Tax: | ₹108.16 lacs | ₹11.74 lacs | +821.31% |
| Net Profit: | ₹79.95 lacs | ₹19.31 lacs | +314.00% |
| Basic & Diluted EPS: | ₹1.06 | ₹0.26 | +307.69% |
Nine-Month Performance Overview
For the nine months ended December 31, 2025, the company reported net profit of ₹351.56 lacs compared to ₹220.50 lacs in the corresponding period last year, reflecting a 59.37% increase. Revenue from operations for the nine-month period stood at ₹27,382.92 lacs against ₹27,639.52 lacs in the previous year.
| Nine-Month Metrics: | 9M FY26 | 9M FY25 | Change (%) |
|---|---|---|---|
| Revenue from Operations: | ₹27,382.92 lacs | ₹27,639.52 lacs | -0.93% |
| Net Profit: | ₹351.56 lacs | ₹220.50 lacs | +59.37% |
| Basic & Diluted EPS: | ₹4.66 | ₹2.92 | +59.59% |
Cost Management and Operational Efficiency
The company's improved profitability was driven by effective cost management across various expense categories. Total expenses decreased by 12.31% to ₹8,126.18 lacs in Q3FY26. Key expense components included cost of raw materials consumed at ₹4,424.56 lacs, employee benefits expense of ₹1,638.02 lacs, and power & fuel costs of ₹1,219.57 lacs.
Regulatory Compliance and Corporate Governance
The financial results were prepared in accordance with Indian Accounting Standards (Ind AS) prescribed under Section 133 of the Companies Act, 2013. The results underwent limited review by statutory auditors P K M B & Co., Chartered Accountants, and were approved by the Audit Committee before board approval. The company operates with a single reportable business segment of yarn manufacturing and has no subsidiary, associate, or joint venture companies as of December 31, 2025.
Share Capital and Market Information
Reliance Chemotex Industries maintains a paid-up equity share capital of ₹754.36 lacs with face value of ₹10 per share. The company trades on BSE with scrip code 503162 and on NSE with trading symbol RELCHEMO. As per regulatory requirements, the trading window closure that was implemented until February 13, 2026, has been lifted following the results announcement.
Historical Stock Returns for Reliance Chemotex
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -3.04% | -3.68% | +3.66% | -29.73% | -32.23% | -47.75% |

































